Malaria
-
From gene editing to death traps, Seattle scientists innovate in race to end malaria
Nov 2, 2016News Hour: When Kayode Ojo first fell sick with malaria as a young boy in Nigeria, his grandfather shunned modern medicine, venturing into the bush to search for herbs and plants to treat the disease. Having... -
Health leaders discussed about financing for global HIV, TB and Malaria problems
Oct 22, 2016News Hour: On the occasion of the Global Fund’s Fifth Replenishment launch, Friends of The Global Fight against AIDS, TB and Malaria organized a get together for civil society, diplomatic and private sector leaders for an... -
Health ministers adopt new plan for malaria elimination in the Americas
Oct 1, 2016News Hour: Noting that malaria “remains a serious threat” in the Americas that has resurged where efforts against the disease have weakened, health ministers from across the Region today adopted a new plan for malaria elimination... -
Global malaria progress and challenges in 2016
Sep 19, 2016News Hour: Malaria is a mosquito-borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single-celled microorganisms) belonging to the Plasmodium type. Over the past 15 years, there has been a... -
Sri Lanka, a malaria-free nation
Sep 17, 2016News Hour: “Sri Lanka’s achievement is truly remarkable. In the mid-20th century it was among the most malaria-affected countries, but now it is malaria-free. This is testament to the courage and vision of its leaders, and... -
Ending malaria by protecting mosquitoes
Sep 7, 2016News Hour: As a scientist who has worked in malaria for more than 30 years, I can truthfully say the numbers are dramatic. Two years ago along the Lake Kariba districts in Zambia’s Southern Province, one... -
The Union welcomes The Global Fund and Stop TB Partnership joint agreement on TB drugs and treatment access
Jun 27, 2016News Hour: Last week, The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) and the STOP TB Partnership signed an agreement to optimise access to TB drugs and treatment services. The Union welcomes... -
Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment
Jun 24, 2016News Hour: Novartis announced that it will further expand its long-standing partnership with Medicines for Malaria Venture (MMV). Novartis will lead the development of antimalarial compound KAF156 with scientific and financial support from MMV in collaboration...
